1	Gillette	_	NNP	_	_	6	SBJ	_	_
2	Co.	_	NNP	_	_	1	POSTHON	_	_
3	,	_	,	_	_	1	P	_	_
4	Boston	_	NNP	_	_	1	APPO	_	_
5	,	_	,	_	_	1	P	_	_
6	said	_	VBD	_	_	0	ROOT	_	_
7	it	_	PRP	_	_	8	SBJ	_	_
8	is	_	VBZ	_	_	6	OBJ	_	_
9	planning	_	VBG	_	_	8	VC	_	_
10	to	_	TO	_	_	9	OPRD	_	_
11	restructure	_	VB	_	_	10	IM	_	_
12	its	_	PRP$	_	_	15	NMOD	_	_
13	South	_	JJ	_	_	14	AMOD	_	_
14	African	_	JJ	_	_	15	NMOD	_	_
15	subsidiary	_	NN	_	_	11	OBJ	_	_
16	.	_	.	_	_	6	P	_	_

1	Under	_	IN	_	_	8	LOC	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	plan	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	8	P	_	_
5	Gillette	_	NNP	_	_	7	NAME	_	_
6	South	_	NNP	_	_	7	NAME	_	_
7	Africa	_	NNP	_	_	8	SBJ	_	_
8	will	_	MD	_	_	0	ROOT	_	_
9	sell	_	VB	_	_	8	VC	_	_
10	manufacturing	_	NN	_	_	11	NMOD	_	_
11	facilities	_	NNS	_	_	9	OBJ	_	_
12	in	_	IN	_	_	11	LOC	_	_
13	Springs	_	NNP	_	_	12	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	South	_	NNP	_	_	16	NAME	_	_
16	Africa	_	NNP	_	_	13	APPO	_	_
17	,	_	,	_	_	13	P	_	_
18	and	_	CC	_	_	11	COORD	_	_
19	its	_	PRP$	_	_	20	NMOD	_	_
20	business	_	NN	_	_	18	CONJ	_	_
21	in	_	IN	_	_	20	NMOD	_	_
22	toiletries	_	NNS	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	plastic	_	NN	_	_	25	NMOD	_	_
25	bags	_	NNS	_	_	23	CONJ	_	_
26	to	_	TO	_	_	9	DTV	_	_
27	Twins	_	NNP	_	_	28	NAME	_	_
28	Pharmaceuticals	_	NNP	_	_	26	PMOD	_	_
29	Ltd.	_	NNP	_	_	28	POSTHON	_	_
30	,	_	,	_	_	28	P	_	_
31	an	_	DT	_	_	32	NMOD	_	_
32	affiliate	_	NN	_	_	28	APPO	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	Anglo	_	NNP	_	_	35	NAME	_	_
35	American	_	NNP	_	_	33	PMOD	_	_
36	Corp.	_	NNP	_	_	35	POSTHON	_	_
37	,	_	,	_	_	35	P	_	_
38	a	_	DT	_	_	41	NMOD	_	_
39	South	_	JJ	_	_	40	AMOD	_	_
40	African	_	JJ	_	_	41	NMOD	_	_
41	company	_	NN	_	_	35	APPO	_	_
42	.	_	.	_	_	8	P	_	_

1	Terms	_	NNS	_	_	2	SBJ	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	not	_	RB	_	_	2	ADV	_	_
4	disclosed	_	VBN	_	_	2	VC	_	_
5	.	_	.	_	_	2	P	_	_

1	A	_	DT	_	_	3	NMOD	_	_
2	final	_	JJ	_	_	3	NMOD	_	_
3	agreement	_	NN	_	_	4	SBJ	_	_
4	has	_	VBZ	_	_	23	OBJ	_	_
5	not	_	RB	_	_	4	ADV	_	_
6	been	_	VBN	_	_	4	VC	_	_
7	signed	_	VBN	_	_	6	VC	_	_
8	,	_	,	_	_	4	P	_	_
9	and	_	CC	_	_	4	COORD	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	moves	_	NNS	_	_	12	SBJ	_	_
12	will	_	MD	_	_	9	CONJ	_	_
13	not	_	RB	_	_	12	ADV	_	_
14	have	_	VB	_	_	12	VC	_	_
15	a	_	DT	_	_	17	NMOD	_	_
16	material	_	JJ	_	_	17	NMOD	_	_
17	effect	_	NN	_	_	14	OBJ	_	_
18	on	_	IN	_	_	17	LOC	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	company	_	NN	_	_	18	PMOD	_	_
21	,	_	,	_	_	23	P	_	_
22	Gillette	_	NNP	_	_	23	SBJ	_	_
23	said	_	VBD	_	_	0	ROOT	_	_
24	.	_	.	_	_	23	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	company	_	NN	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	it	_	PRP	_	_	5	SBJ	_	_
5	is	_	VBZ	_	_	3	OBJ	_	_
6	part	_	NN	_	_	5	PRD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	a	_	DT	_	_	11	NMOD	_	_
9	continuing	_	VBG	_	_	11	NMOD	_	_
10	world-wide	_	JJ	_	_	11	NMOD	_	_
11	restructuring	_	NN	_	_	7	PMOD	_	_
12	in	_	IN	_	_	16	LOC	_	_
13	which	_	WDT	_	_	12	PMOD	_	_
14	it	_	PRP	_	_	15	SBJ	_	_
15	has	_	VBZ	_	_	11	NMOD	_	_
16	downsized	_	VBN	_	_	15	VC	_	_
17	or	_	CC	_	_	16	COORD	_	_
18	sold	_	VBN	_	_	17	CONJ	_	_
19	operations	_	NNS	_	_	16	OBJ	_	_
20	in	_	IN	_	_	19	LOC	_	_
21	several	_	JJ	_	_	22	NMOD	_	_
22	countries	_	NNS	_	_	20	PMOD	_	_
23	.	_	.	_	_	3	P	_	_

1	Gillette	_	NNP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	its	_	PRP$	_	_	5	NMOD	_	_
4	continued	_	JJ	_	_	5	NMOD	_	_
5	presence	_	NN	_	_	10	SBJ	_	_
6	in	_	IN	_	_	5	LOC	_	_
7	South	_	NNP	_	_	8	NAME	_	_
8	Africa	_	NNP	_	_	6	PMOD	_	_
9	``	_	``	_	_	10	P	_	_
10	enables	_	VBZ	_	_	2	OBJ	_	_
11	it	_	PRP	_	_	10	OBJ	_	_
12	to	_	TO	_	_	10	OPRD	_	_
13	make	_	VB	_	_	12	IM	_	_
14	meaningful	_	JJ	_	_	15	NMOD	_	_
15	contributions	_	NNS	_	_	13	OBJ	_	_
16	to	_	TO	_	_	15	NMOD	_	_
17	South	_	JJ	_	_	18	AMOD	_	_
18	African	_	JJ	_	_	19	NMOD	_	_
19	society	_	NN	_	_	16	PMOD	_	_
20	,	_	,	_	_	16	P	_	_
21	to	_	TO	_	_	16	COORD	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	lives	_	NNS	_	_	21	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	its	_	PRP$	_	_	26	NMOD	_	_
26	employees	_	NNS	_	_	24	PMOD	_	_
27	and	_	CC	_	_	21	COORD	_	_
28	to	_	TO	_	_	27	CONJ	_	_
29	the	_	DT	_	_	30	NMOD	_	_
30	communities	_	NNS	_	_	28	PMOD	_	_
31	in	_	IN	_	_	34	LOC	_	_
32	which	_	WDT	_	_	31	PMOD	_	_
33	it	_	PRP	_	_	34	SBJ	_	_
34	operates	_	VBZ	_	_	30	NMOD	_	_
35	.	_	.	_	_	10	P	_	_
36	''	_	''	_	_	10	P	_	_

1	Gillette	_	NNP	_	_	3	NAME	_	_
2	South	_	NNP	_	_	3	NAME	_	_
3	Africa	_	NNP	_	_	4	SBJ	_	_
4	employs	_	VBZ	_	_	0	ROOT	_	_
5	about	_	RB	_	_	7	NMOD	_	_
6	250	_	CD	_	_	5	DEP	_	_
7	people	_	NNS	_	_	4	OBJ	_	_
8	.	_	.	_	_	4	P	_	_

1	About	_	RB	_	_	3	NMOD	_	_
2	60	_	CD	_	_	1	DEP	_	_
3	%	_	NN	_	_	8	SBJ	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	work	_	NN	_	_	7	NMOD	_	_
7	force	_	NN	_	_	4	PMOD	_	_
8	will	_	MD	_	_	20	OBJ	_	_
9	continue	_	VB	_	_	8	VC	_	_
10	with	_	IN	_	_	9	ADV	_	_
11	Gillette	_	NNP	_	_	10	PMOD	_	_
12	or	_	CC	_	_	9	COORD	_	_
13	transfer	_	VB	_	_	12	CONJ	_	_
14	to	_	TO	_	_	13	DIR	_	_
15	Twins	_	NNP	_	_	16	NAME	_	_
16	Pharmaceuticals	_	NNPS	_	_	14	PMOD	_	_
17	,	_	,	_	_	20	P	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	company	_	NN	_	_	20	SBJ	_	_
20	said	_	VBD	_	_	0	ROOT	_	_
21	.	_	.	_	_	20	P	_	_

